Akoya Biosciences Inc (AKYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 26,487 | 25,215 | 23,521 | 21,410 | 21,219 |
| Cost of Goods | 9,867 | 9,939 | 11,405 | 9,117 | 9,173 |
| Gross Profit | 16,620 | 15,276 | 12,116 | 12,293 | 12,046 |
| Operating Expenses | 26,926 | 27,766 | 31,763 | 29,846 | 29,810 |
| Operating Income | -9,439 | -11,551 | -19,242 | -17,436 | -17,591 |
| Interest Expense | 2,293 | 2,239 | 2,175 | 2,054 | 1,847 |
| Other Income | 908 | 889 | 632 | 717 | 537 |
| Pre-tax Income | -10,824 | -12,901 | -20,785 | -18,773 | -18,901 |
| Income Tax | -22 | 15 | 18 | 29 | -26 |
| Net Income Continuous | -10,802 | -12,916 | -20,803 | -18,802 | -18,875 |
| Net Income | $-10,802 | $-12,916 | $-20,803 | $-18,802 | $-18,875 |
| EPS Basic Total Ops | -0.17 | -0.26 | -0.51 | -0.49 | -0.49 |
| EPS Basic Continuous Ops | -0.16 | -0.26 | -0.51 | -0.49 | -0.50 |
| EPS Diluted Total Ops | -0.17 | -0.26 | -0.51 | -0.49 | -0.49 |
| EPS Diluted Continuous Ops | -0.16 | -0.26 | -0.51 | -0.49 | -0.50 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.26 | -0.51 | N/A | N/A |
| EBITDA(a) | $-7,333 | $-8,975 | $-17,155 | $-15,315 | $-15,690 |